ProTransit Dermal Therapy

In May 2013, Drs. Madsen and Labhasetwar formed this wholly owned subsidiary to commercialize the patented nanoparticles in the topical application market – sun care, skincare, and cosmetics. The company is currently performing testing of the ability of Pro-NP™ to control free radical formation in skin tissue upon exposure to UV rays.